Additionally, a cohort study has shown that elevated plasma p-tau 181 levels are closely correlated with the occurrence of psychiatric symptoms (delusions and hallucinations) in AD, emphasizing the potential use of plasma p-tau 181 as a biomarker for neuropsychiatric diseases in AD [53]. The gene discussed is MAPT; the disease is Hallucinations.